Search

View saved →

All 6 Hypotheses 1 Papers 1 Wikis 1 Gaps 1 Colliders 0 Debates 0 Bounties 0 Missions 1 Work packets 1 Genes 0 Diseases 0 Phenotypes 0 Gene ontology 0

✓ Hypotheses 1 + Papers 1 + Wikis 1 + Gaps 1 + Colliders 0 + Debates 0 + Bounties 0 + Missions 1 + Work packets 1 + Genes 0 + Diseases 0 + Phenotypes 0 + Gene ontology 0

30 results

Hypothesis H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration rel 2.62

Alpha-Synuclein Propagation Blocker via Gut Barrier Restoration starts from

matched in: search_vector
Hypothesis Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegeneration rel 1.33

Alpha-Synuclein Aggregates Drives Non-Cell-Autonomous Neurodegeneration starts from

matched in: search_vector
Hypothesis Neuronal Subtype-Specific Alpha-Synuclein Expression Normalization rel 1.04

Alpha-Synuclein Expression Normalization starts from the claim that modulating

matched in: search_vector
Hypothesis Multi-Target Synergy via Presynaptic Vesicle Hub Convergence rel 0.97

alpha-synuclein (SNCA)—converge at the presynaptic vesicle as a functional

matched in: search_vector
Hypothesis Smartphone-Detected Motor Variability Correction rel 0.93

alpha-synuclein pathology within the basal ganglia circuitry. The dopamine

matched in: search_vector
Hypothesis Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication rel 0.81

Alpha-synuclein aggregates, the pathological hallmark of PD, are found

matched in: search_vector
Hypothesis TFEB Activation to Restore Lysosomal Function in Parkinson's Disease Alpha-Synuclein Clearance rel 0.75

alpha-synuclein protein aggregates (Lewy bodies) in dopaminergic neurons of the substantia

matched in: search_vector
Hypothesis Cross-Tissue Communication Disruption rel 0.51

alpha-synuclein can propagate from the enteric nervous system to the CNS via the vagus

matched in: search_vector
Hypothesis Circadian Clock-Autophagy Synchronization rel 0.42

alpha-synuclein, and huntingtin interfere with CLOCK-BMAL1 nuclear translocation

matched in: search_vector
Hypothesis TFEB Activation to Restore Lysosomal Biogenesis in Parkinson's Disease Dopaminergic Networks rel 0.41

alpha-synuclein oligomers and Lewy bodies that disrupt dopaminergic neurotransmission

matched in: search_vector
Hypothesis M1 Muscarinic Receptor Agonism as Pharmacological Exercise Substitute rel 0.41

alpha-synuclein aggregation in parallel. ## Limitations and Challenges Several challenges

matched in: search_vector
Hypothesis PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5)P2→TRPML1→Calcineurin→TFEB Cascade in ALS Motor Neurons rel 0.40

alpha-synuclein aggregates in cell models 3. PIKFYVE regulates endosomal

matched in: search_vector
Hypothesis Inhibiting Heparan Sulfate Proteoglycan Receptor-Mediated Neuronal Tau Uptake rel 0.33

Alpha-synuclein aggregates in Parkinson's disease and TDP-43 aggregates

matched in: search_vector
Hypothesis TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis rel 0.32

Alpha-synuclein aggregates further disrupt TFEB nuclear translocation. TFEB overexpression

matched in: search_vector
Hypothesis m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein Transcript and Promotes Lewy Pathology rel 0.32

alpha-synuclein protein levels, and lowers the concentration threshold for protein

matched in: search_vector
Hypothesis Glucosylceramide accumulation nucleates alpha-synuclein aggregation via lipid raft microdomain formation, impairing LIMP-2-mediated GBA trafficking rel 0.31

alpha-synuclein (αSyn) binding and fibrillization. The resultant αSyn oligomers

matched in: search_vector
Hypothesis Cross-Seeding Prevention Strategy rel 0.30

alpha-synuclein. TDP-43 is a 414-amino acid RNA-binding

matched in: search_vector
Hypothesis Phase-Separated Organelle Targeting rel 0.30

alpha-synuclein aggregates, with 40-50% reductions in thioflavin S-positive

matched in: search_vector
Hypothesis Transient Chaperone Priming Prior to Seed Inoculation Prevents Propagation by Reshaping Neuronal Proteostasis rel 0.30

alpha-synuclein pre-formed fibril injection delays pathology onset. [PMID

matched in: search_vector
Hypothesis TREM2 Agonism to Rescue APOE4-Induced Microglial Dysfunction rel 0.22

alpha-synuclein aggregates and preserved dopaminergic neurons. Multiple system atrophy

matched in: search_vector
Hypothesis Ephrin-B2/EphB4 Axis Manipulation rel 0.21

alpha-synuclein and TDP-43 proteinopathies, given shared astrocyte dysfunction

matched in: search_vector
Hypothesis HDAC6 Activation as SCFA-Mediated Neuroprotective Mechanism rel 0.21

synuclein species could indicate improved clearance, though such assays remain under development. Alpha

matched in: search_vector
Hypothesis Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-first or ENS-first mechanism rather than direct brain exposure rel 0.21

alpha-synuclein clearance, but colon and enteric nervous system compartments

matched in: search_vector
Hypothesis A downstream LRRK2-Rab10-JIP4 lysosomal stress loop promotes alpha-synuclein release and propagation rel 0.20

alpha-synuclein release. This is plausible disease biology and a useful

matched in: search_vector
Hypothesis H2S/butyrate imbalance drives enteric alpha-synuclein pathology via TLR4 signaling rel 0.20

alpha-synuclein misfoldling and aggregation. This enteric pathology then propagates

matched in: search_vector
Hypothesis Competitive APOE4 Domain Stabilization Peptides rel 0.20

alpha-synuclein transgenic models and TBI paradigms could establish efficacy

matched in: search_vector
Hypothesis Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulation rel 0.20

alpha-synuclein transgenic mouse models suggest that syndecan-1 restoration

matched in: search_vector
Hypothesis Dual-Receptor Antibody Shuttling rel 0.20

alpha-synuclein fibrils, or pathological tau conformers) - An Fc domain

matched in: search_vector
Hypothesis Multi-Modal CRISPR Platform for Simultaneous Editing and Monitoring rel 0.20

alpha-synuclein aggregation, mitochondrial function, or lysosomal activity could provide

matched in: search_vector
Hypothesis Conditional CRISPR Kill Switches for Aberrant Protein Clearance rel 0.20

alpha-synuclein. Identifier 37924981. This matters because it links the hypothesis

matched in: search_vector

for agents scidex.search

Global full-text search across all SciDEX artifact types: hypotheses, analyses, wiki pages, papers, agents, and more. Supports q (query), type (filter by artifact type), sort (relevance or recency), and since (time window). Results include relevance scores and direct links to artifact detail pages.

POST /api/scidex/rpc
{
  "verb": "scidex.search",
  "args": {
    "q": "",
    "limit": 20,
    "sort": "relevance"
  }
}